AETOS’ UK Broke Even in Another Year: FY24 Revenue Jumped 20%

The UK-regulated entity of AETOS, a contracts for differences (CFDs) broker, closed the fiscal year ending 31 March 2024 with a turnover of £479,421, 20 per cent higher than the previous fiscal year’s £399,017.

Broking Commission Revenue Is Minuscule

According to Companies House filings, the broker generated £474,660 of its revenue from management services fees, while the remaining £4,761 came from broking commissions. In the previous fiscal year, revenue from broking commissions was nil.

“As a service provider, the directors consider that the key financial risks faced by the company relate to market risk and the need to maintain sufficient liquidity to satisfy regulatory capital requirements and working capital needs,” the filing stated.

“The company does not take trade positions that expose it to material price risk, nor does it have significant exposure to movements in foreign exchange risk.”

However, the broker’s administrative expenses also increased, almost entirely consuming the yearly turnover, as in the previous fiscal year. The UK company has six staff members on average, including three management and three sales and marketing staff, and paid £311,042 in annual salaries in FY24.

After considering interest income of £1,774, the broker ended the fiscal year with a net profit of £2,408, compared to FY23’s £1,004.

Income statement of AETOS UK

A Global Brand

AETOS Capital Group (UK) Limited offers CFDs trading with forex pairs, metals, energy, and indices. The UK unit is a wholly owned subsidiary of AETOS’s Cayman Islands-registered entity, which gained an operational licence in 2021.

In addition to the UK and the Cayman Islands, the AETOS brand is operated by entities regulated in Australia, Vanuatu, and Mauritius.

Meanwhile, several other UK divisions of global brokerages reported mixed turnover and profits for the last fiscal year. While the UK division of OANDA generated £16.32 million in revenue, a slight drop from the previous fiscal year, Capital Index’s UK entity witnessed a significant 29 per cent decline in turnover.

The UK-regulated entity of AETOS, a contracts for differences (CFDs) broker, closed the fiscal year ending 31 March 2024 with a turnover of £479,421, 20 per cent higher than the previous fiscal year’s £399,017.

Broking Commission Revenue Is Minuscule

According to Companies House filings, the broker generated £474,660 of its revenue from management services fees, while the remaining £4,761 came from broking commissions. In the previous fiscal year, revenue from broking commissions was nil.

“As a service provider, the directors consider that the key financial risks faced by the company relate to market risk and the need to maintain sufficient liquidity to satisfy regulatory capital requirements and working capital needs,” the filing stated.

“The company does not take trade positions that expose it to material price risk, nor does it have significant exposure to movements in foreign exchange risk.”

However, the broker’s administrative expenses also increased, almost entirely consuming the yearly turnover, as in the previous fiscal year. The UK company has six staff members on average, including three management and three sales and marketing staff, and paid £311,042 in annual salaries in FY24.

After considering interest income of £1,774, the broker ended the fiscal year with a net profit of £2,408, compared to FY23’s £1,004.

Income statement of AETOS UK

A Global Brand

AETOS Capital Group (UK) Limited offers CFDs trading with forex pairs, metals, energy, and indices. The UK unit is a wholly owned subsidiary of AETOS’s Cayman Islands-registered entity, which gained an operational licence in 2021.

In addition to the UK and the Cayman Islands, the AETOS brand is operated by entities regulated in Australia, Vanuatu, and Mauritius.

Meanwhile, several other UK divisions of global brokerages reported mixed turnover and profits for the last fiscal year. While the UK division of OANDA generated £16.32 million in revenue, a slight drop from the previous fiscal year, Capital Index’s UK entity witnessed a significant 29 per cent decline in turnover.

This post is originally published on FINANCEMAGNATES.

  • Related Posts

    eToro’s Q2 2025 Forecast Focuses on China, Gold, Biotech, and Robotics

    eToro’s Q2 2025 investment outlook highlights shifting market dynamics and investment trends, examining changes across asset classes, economic policy uncertainty, and movements beyond mega-cap stocks. Global Market Shifts: China and…

    eToro’s Q2 2025 Forecast Focuses on US Tariffs, China, Gold, Biotech, and Robotics

    eToro’s Q2 2025 investment outlook highlights shifting market dynamics and investment trends, examining changes across asset classes, economic policy uncertainty, and movements beyond mega-cap stocks. Global Market Shifts: China and…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Weekly Economic Calendar for 07.04.2025–13.04.2025

    • April 2, 2025
    Weekly Economic Calendar for 07.04.2025–13.04.2025

    U.S. Tariffs Take Effect Tomorrow, Highlighted in eToro’s Q2 2025 Forecast

    • April 1, 2025
    U.S. Tariffs Take Effect Tomorrow, Highlighted in eToro’s Q2 2025 Forecast

    U.S. Tariffs Take Effect Tomorrow, Highlighted in eToro’s Q2 Forecast

    • April 1, 2025
    U.S. Tariffs Take Effect Tomorrow, Highlighted in eToro’s Q2 Forecast

    U.S. Tariffs Come Into Effect Tomorrow, Highlighted in eToro’s Q2 Forecast

    • April 1, 2025
    U.S. Tariffs Come Into Effect Tomorrow, Highlighted in eToro’s Q2 Forecast

    eToro’s Q2 2025 Forecast Focuses on US Tariffs, China, Gold, Biotech, and Robotics

    • April 1, 2025
    eToro’s Q2 2025 Forecast Focuses on US Tariffs, China, Gold, Biotech, and Robotics

    eToro’s Q2 2025 Forecast Focuses on China, Gold, Biotech, and Robotics

    • April 1, 2025
    eToro’s Q2 2025 Forecast Focuses on China, Gold, Biotech, and Robotics